相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resolution of Acute Inflammation in the Lung
Bruce D. Levy et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 76 (2014)
Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages
Min Wan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes
Xue Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Neutrophil-Derived Cathelicidin Promotes Adhesion of Classical Monocytes
Sarawuth Wantha et al.
CIRCULATION RESEARCH (2013)
Involvement of the P2X7 Purinergic Receptor and c-Jun N-Terminal and Extracellular Signal-Regulated Kinases in Cyclooxygenase-2 and Prostaglandin E2 Induction by LL-37
Pareena Chotjumlong et al.
JOURNAL OF INNATE IMMUNITY (2013)
Lack of Neutrophil-Derived CRAMP Reduces Atherosclerosis in Mice
Yvonne Doering et al.
CIRCULATION RESEARCH (2012)
Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis
William L. Smith et al.
CHEMICAL REVIEWS (2011)
Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease
Jesper Z. Haeggstrom et al.
CHEMICAL REVIEWS (2011)
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases
Nishkantha Arulkumaran et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1
Min Wan et al.
FASEB JOURNAL (2011)
Neutrophil-Derived Cathelicidin Protects from Neointimal Hyperplasia
Oliver Soehnlein et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
The Role of the P2X7 Receptor in Infectious Diseases
Catherine M. Miller et al.
PLOS PATHOGENS (2011)
Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis
Olof Radmark et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration
Julia Esser et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
LL-37 Directs Macrophage Differentiation toward Macrophages with a Proinflammatory Signature
Anne M. van der Does et al.
JOURNAL OF IMMUNOLOGY (2010)
Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion
Anders Gabrielsen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Control of free arachidonic acid levels by phospholipases A2 and lysophospholipid acyltransferases
Gema Perez-Chacon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils
Zhifang Zhang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Cyclooxygenases: structural and functional insights
Carol A. Rouzer et al.
JOURNAL OF LIPID RESEARCH (2009)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Leukotriene B4 triggers release of the cathelicidin LL-37 from human neutrophils:: novel lipid-peptide interactions in innate immune responses
Min Wan et al.
FASEB JOURNAL (2007)
Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice
Tillmann Cyrus et al.
BLOOD (2007)
Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor
Pablo Pelegrin et al.
EMBO JOURNAL (2006)
Involvement of the antimicrobial peptide LL-37 in human atherosclerosis
Kristina Edfeldt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Antimicrobial peptide LL-37 internalized by immature human dendritic cells alters their phenotype
L. Bandholtz et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37
S Tokumaru et al.
JOURNAL OF IMMUNOLOGY (2005)
Cyclooxygenases, thromboxane, and atherosclerosis -: Plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism
KM Egan et al.
CIRCULATION (2005)
Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells
YE Lau et al.
INFECTION AND IMMUNITY (2005)
A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release
A Elssner et al.
JOURNAL OF IMMUNOLOGY (2004)
The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes
DME Bowdish et al.
JOURNAL OF IMMUNOLOGY (2004)
Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice
T Kobayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Innate antimicrobial peptide protects the skin from invasive bacterial infection
V Nizet et al.
NATURE (2001)
Lipid mediator class switching during acute inflammation: signals in resolution
BD Levy et al.
NATURE IMMUNOLOGY (2001)
Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3
OE Sorensen et al.
BLOOD (2001)
LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells
D Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
